How US smokers are using the IQOS heated tobacco system
Uptake and Patterns of Use of the IQOS Heated Tobacco System by US Smokers
This study looks at how smokers in the U.S. are using the IQOS heated tobacco system, which heats tobacco to create a vapor, to see if it's helping them switch from regular cigarettes or if it's drawing in new smokers, so we can better understand its impact on health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10540695 on NIH RePORTER |
What this research studies
This research investigates how smokers in the U.S. are adopting and using the IQOS heated tobacco system, which heats tobacco to create a nicotine-containing aerosol. The study focuses on understanding the demographics of IQOS users, their smoking behaviors, and the potential health impacts of this product. By collecting data from various retail locations and analyzing user patterns, the research aims to provide insights into whether IQOS is helping smokers switch from traditional cigarettes or if it is attracting new users. This information is crucial for assessing the public health implications of IQOS in the U.S.
Who could benefit from this research
Good fit: Ideal candidates for this research are current smokers who are considering or have already started using the IQOS system.
Not a fit: Patients who do not smoke or are not interested in using heated tobacco products may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could inform public health policies and help smokers make more informed choices about tobacco use.
How similar studies have performed: While there have been studies on tobacco use in other countries, this research is novel in its focus on the U.S. market and the specific patterns of IQOS use.
Where this research is happening
Atlanta, United States
- Georgia State University — Atlanta, United States (Active)
Researchers
- Principal investigator: Weaver, Scott R — Georgia State University
- Study coordinator: Weaver, Scott R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.